Copyright Reports & Markets. All rights reserved.

Global Hemostatic Sponge Market Insights and Forecast to 2026

Buy now

1 Study Coverage

  • 1.1 Hemostatic Sponge Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Hemostatic Sponge Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Hemostatic Sponge Market Size Growth Rate by Type
    • 1.4.2 Microfibrillar Collagen
    • 1.4.3 Chitosan
    • 1.4.4 Other
  • 1.5 Market by Application
    • 1.5.1 Global Hemostatic Sponge Market Size Growth Rate by Application
    • 1.5.2 Surgical Wound Care
    • 1.5.3 General Wound Care
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Hemostatic Sponge Market Size, Estimates and Forecasts
    • 2.1.1 Global Hemostatic Sponge Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Hemostatic Sponge Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Hemostatic Sponge Production Estimates and Forecasts 2015-2026
  • 2.2 Global Hemostatic Sponge, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Hemostatic Sponge Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Hemostatic Sponge Manufacturers Geographical Distribution
  • 2.4 Key Trends for Hemostatic Sponge Markets & Products
  • 2.5 Primary Interviews with Key Hemostatic Sponge Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Hemostatic Sponge Manufacturers by Production Capacity
    • 3.1.1 Global Top Hemostatic Sponge Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Hemostatic Sponge Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Hemostatic Sponge Manufacturers Market Share by Production
  • 3.2 Global Top Hemostatic Sponge Manufacturers by Revenue
    • 3.2.1 Global Top Hemostatic Sponge Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Hemostatic Sponge Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Hemostatic Sponge Revenue in 2019
  • 3.3 Global Hemostatic Sponge Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Hemostatic Sponge Production by Regions

  • 4.1 Global Hemostatic Sponge Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Hemostatic Sponge Regions by Production (2015-2020)
    • 4.1.2 Global Top Hemostatic Sponge Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Hemostatic Sponge Production (2015-2020)
    • 4.2.2 North America Hemostatic Sponge Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Hemostatic Sponge Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Hemostatic Sponge Production (2015-2020)
    • 4.3.2 Europe Hemostatic Sponge Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Hemostatic Sponge Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Hemostatic Sponge Production (2015-2020)
    • 4.4.2 China Hemostatic Sponge Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Hemostatic Sponge Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Hemostatic Sponge Production (2015-2020)
    • 4.5.2 Japan Hemostatic Sponge Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Hemostatic Sponge Import & Export (2015-2020)

5 Hemostatic Sponge Consumption by Region

  • 5.1 Global Top Hemostatic Sponge Regions by Consumption
    • 5.1.1 Global Top Hemostatic Sponge Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Hemostatic Sponge Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Hemostatic Sponge Consumption by Application
    • 5.2.2 North America Hemostatic Sponge Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Hemostatic Sponge Consumption by Application
    • 5.3.2 Europe Hemostatic Sponge Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Hemostatic Sponge Consumption by Application
    • 5.4.2 Asia Pacific Hemostatic Sponge Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Hemostatic Sponge Consumption by Application
    • 5.5.2 Central & South America Hemostatic Sponge Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Hemostatic Sponge Consumption by Application
    • 5.6.2 Middle East and Africa Hemostatic Sponge Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Hemostatic Sponge Market Size by Type (2015-2020)
    • 6.1.1 Global Hemostatic Sponge Production by Type (2015-2020)
    • 6.1.2 Global Hemostatic Sponge Revenue by Type (2015-2020)
    • 6.1.3 Hemostatic Sponge Price by Type (2015-2020)
  • 6.2 Global Hemostatic Sponge Market Forecast by Type (2021-2026)
    • 6.2.1 Global Hemostatic Sponge Production Forecast by Type (2021-2026)
    • 6.2.2 Global Hemostatic Sponge Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Hemostatic Sponge Price Forecast by Type (2021-2026)
  • 6.3 Global Hemostatic Sponge Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Hemostatic Sponge Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Hemostatic Sponge Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Bard
    • 8.1.1 Bard Corporation Information
    • 8.1.2 Bard Overview
    • 8.1.3 Bard Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Bard Product Description
    • 8.1.5 Bard Related Developments
  • 8.2 Pfizer
    • 8.2.1 Pfizer Corporation Information
    • 8.2.2 Pfizer Overview
    • 8.2.3 Pfizer Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Pfizer Product Description
    • 8.2.5 Pfizer Related Developments
  • 8.3 Ethicon
    • 8.3.1 Ethicon Corporation Information
    • 8.3.2 Ethicon Overview
    • 8.3.3 Ethicon Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Ethicon Product Description
    • 8.3.5 Ethicon Related Developments
  • 8.4 Gelita Medical
    • 8.4.1 Gelita Medical Corporation Information
    • 8.4.2 Gelita Medical Overview
    • 8.4.3 Gelita Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Gelita Medical Product Description
    • 8.4.5 Gelita Medical Related Developments
  • 8.5 Equimedical
    • 8.5.1 Equimedical Corporation Information
    • 8.5.2 Equimedical Overview
    • 8.5.3 Equimedical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Equimedical Product Description
    • 8.5.5 Equimedical Related Developments
  • 8.6 Biocer
    • 8.6.1 Biocer Corporation Information
    • 8.6.2 Biocer Overview
    • 8.6.3 Biocer Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 Biocer Product Description
    • 8.6.5 Biocer Related Developments
  • 8.7 Celox
    • 8.7.1 Celox Corporation Information
    • 8.7.2 Celox Overview
    • 8.7.3 Celox Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Celox Product Description
    • 8.7.5 Celox Related Developments
  • 8.8 Hemostasis
    • 8.8.1 Hemostasis Corporation Information
    • 8.8.2 Hemostasis Overview
    • 8.8.3 Hemostasis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 Hemostasis Product Description
    • 8.8.5 Hemostasis Related Developments
  • 8.9 MBP
    • 8.9.1 MBP Corporation Information
    • 8.9.2 MBP Overview
    • 8.9.3 MBP Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 MBP Product Description
    • 8.9.5 MBP Related Developments
  • 8.10 Medira
    • 8.10.1 Medira Corporation Information
    • 8.10.2 Medira Overview
    • 8.10.3 Medira Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 Medira Product Description
    • 8.10.5 Medira Related Developments
  • 8.11 Hemotec Medical
    • 8.11.1 Hemotec Medical Corporation Information
    • 8.11.2 Hemotec Medical Overview
    • 8.11.3 Hemotec Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 Hemotec Medical Product Description
    • 8.11.5 Hemotec Medical Related Developments
  • 8.12 Starch Medical
    • 8.12.1 Starch Medical Corporation Information
    • 8.12.2 Starch Medical Overview
    • 8.12.3 Starch Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.12.4 Starch Medical Product Description
    • 8.12.5 Starch Medical Related Developments
  • 8.13 Success Pharmaceutical
    • 8.13.1 Success Pharmaceutical Corporation Information
    • 8.13.2 Success Pharmaceutical Overview
    • 8.13.3 Success Pharmaceutical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.13.4 Success Pharmaceutical Product Description
    • 8.13.5 Success Pharmaceutical Related Developments
  • 8.14 Changsha Hairun
    • 8.14.1 Changsha Hairun Corporation Information
    • 8.14.2 Changsha Hairun Overview
    • 8.14.3 Changsha Hairun Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.14.4 Changsha Hairun Product Description
    • 8.14.5 Changsha Hairun Related Developments

9 Hemostatic Sponge Production Forecast by Regions

  • 9.1 Global Top Hemostatic Sponge Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Hemostatic Sponge Regions Forecast by Production (2021-2026)
  • 9.3 Key Hemostatic Sponge Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Hemostatic Sponge Consumption Forecast by Region

  • 10.1 Global Hemostatic Sponge Consumption Forecast by Region (2021-2026)
  • 10.2 North America Hemostatic Sponge Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Hemostatic Sponge Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Hemostatic Sponge Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Hemostatic Sponge Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Hemostatic Sponge Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Hemostatic Sponge Sales Channels
    • 11.2.2 Hemostatic Sponge Distributors
  • 11.3 Hemostatic Sponge Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Hemostatic Sponge Industry
  • 12.2 Market Trends
  • 12.3 Market Opportunities and Drivers
  • 12.4 Market Challenges
  • 12.5 Hemostatic Sponge Market Risks/Restraints
  • 12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Hemostatic Sponge Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Hemostatic Sponge market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hemostatic Sponge market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Hemostatic Sponge market is segmented into
    Microfibrillar Collagen
    Chitosan
    Other

    Segment by Application, the Hemostatic Sponge market is segmented into
    Surgical Wound Care
    General Wound Care

    Regional and Country-level Analysis
    The Hemostatic Sponge market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Hemostatic Sponge market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
    Competitive Landscape and Hemostatic Sponge Market Share Analysis

    Hemostatic Sponge market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Hemostatic Sponge by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Hemostatic Sponge business, the date to enter into the Hemostatic Sponge market, Hemostatic Sponge product introduction, recent developments, etc.
    The major vendors covered:
    Bard
    Pfizer
    Ethicon
    Gelita Medical
    Equimedical
    Biocer
    Celox
    Hemostasis
    MBP
    Medira
    Hemotec Medical
    Starch Medical
    Success Pharmaceutical
    Changsha Hairun

    Buy now